297172-19-1 Usage
Description
Imidazo[1,5-a]pyrazine,5,6,7,8-tetrahydrois a chemical compound belonging to the imidazo[1,5-a]pyrazine family. It is characterized by its unique molecular structure, which includes a tetrahydroimidazo ring fused with a pyrazine ring. Imidazo[1,5-a]pyrazine,5,6,7,8-tetrahydrohas attracted interest due to its potential applications in various fields, particularly in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
Imidazo[1,5-a]pyrazine,5,6,7,8-tetrahydrois used as a KRAS G12C inhibitor for antitumor agents. Imidazo[1,5-a]pyrazine,5,6,7,8-tetrahydrotargets the KRAS G12C mutation, which is a common genetic alteration found in various types of cancer, including non-small cell lung cancer, colorectal cancer, and pancreatic cancer. By inhibiting the KRAS G12C protein, this compound can potentially disrupt the signaling pathways that promote tumor growth and progression, offering a novel therapeutic approach for patients with KRAS G12C-mutated cancers.
Check Digit Verification of cas no
The CAS Registry Mumber 297172-19-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,7,1,7 and 2 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 297172-19:
(8*2)+(7*9)+(6*7)+(5*1)+(4*7)+(3*2)+(2*1)+(1*9)=171
171 % 10 = 1
So 297172-19-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H9N3/c1-2-9-5-8-4-6(9)3-7-1/h4-5,7H,1-3H2
297172-19-1Relevant articles and documents
FUSED IMIDAZOLYL DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS
-
Paragraph 36, (2015/07/07)
The present invention relates to new fused imidazolyl derivatives having a high affinity for sigma receptors, especially sigma-1 receptors, as well as to the process for the preparation thereof, to compositions comprising them, and to their use as medicam
